Lingenfelter Erin, Drapkin Zachary, Fritz Kelly, Youngquist Scott, Madsen Troy, Fix Megan
Inpatient Pharmacy Services, University of Utah, Salt Lake City, UT, USA.
Division of Emergency Medicine, University of Utah, Salt Lake City, UT, USA.
Am J Emerg Med. 2016 Aug;34(8):1600-3. doi: 10.1016/j.ajem.2016.05.076. Epub 2016 May 31.
We sought to determine whether an emergency department (ED) pharmacist could aid in the monitoring and correction of inappropriate empiric antibiotic selection for urinary tract infections in an outpatient ED population.
Urine cultures with greater than 100 000 CFU/mL bacteria from the University of Utah Emergency Department over 1 year (October 2011-Sept 2012) were identified using our electronic medical record system. Per ED protocol, an ED pharmacist reviews all cultures and performs a chart review of patient symptoms, diagnosis, and discharge antibiotics to determine whether the treatment was appropriate. A retrospective review of this process was performed to identify how often inappropriate treatment was recognized and intervened on by an ED pharmacist.
Of the 180 cultures included, a total of 42 (23%) of empiric discharge treatments were considered inappropriate and required intervention. In 35 (83%) of 42 patients, the ED pharmacist was able to contact the patient and make appropriate changes; the remaining 7 patients were unable to be contacted, and no change could be made in their treatment.
A chart review of all urine cultures with greater than 100 000 CFU/mL performed by an ED pharmacist helped identify inappropriate treatment in 23% of patients discharged to home with the diagnosis of urinary tract infection. Of these patients who had received inappropriate treatment, an ED pharmacist was able to intervene in 83% of cases. These data highlight the role of ED pharmacists in improving patient care after discharge.
我们试图确定急诊科药剂师是否能够协助监测和纠正门诊急诊科患者尿路感染经验性抗生素选择不当的问题。
使用我们的电子病历系统,识别出犹他大学急诊科在1年(2011年10月至2012年9月)内尿液培养细菌菌落形成单位每毫升超过100000的样本。按照急诊科规程,一名急诊科药剂师会查看所有培养结果,并对患者症状、诊断及出院时使用的抗生素进行病历审查,以确定治疗是否恰当。对这一过程进行回顾性审查,以确定急诊科药剂师识别并干预不当治疗的频率。
在纳入的180份培养样本中,共有42例(23%)经验性出院治疗被认为不当,需要干预。在42例患者中的35例(83%)中,急诊科药剂师能够联系到患者并做出适当调整;其余7例患者无法联系到,其治疗无法更改。
由急诊科药剂师对所有尿液培养细菌菌落形成单位每毫升超过100000的样本进行病历审查,有助于识别出23%诊断为尿路感染并出院回家的患者的不当治疗。在这些接受了不当治疗的患者中,急诊科药剂师能够在83%的病例中进行干预。这些数据凸显了急诊科药剂师在改善患者出院后护理方面的作用。